- Home
- TTI vs SEPN Comparison
TTI vs SEPN Comparison
Compare TTI & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTI
- SEPN
- Stock Information
- Founded
- TTI 1981
- SEPN 2022
- Country
- TTI United States
- SEPN United States
- Employees
- TTI N/A
- SEPN N/A
- Industry
- TTI Oil & Gas Production
- SEPN
- Sector
- TTI Energy
- SEPN
- Exchange
- TTI Nasdaq
- SEPN NYSE
- Market Cap
- TTI 363.3M
- SEPN 311.6M
- IPO Year
- TTI 1990
- SEPN 2024
- Fundamental
- Price
- TTI $2.68
- SEPN $9.25
- Analyst Decision
- TTI Strong Buy
- SEPN Buy
- Analyst Count
- TTI 2
- SEPN 4
- Target Price
- TTI $5.25
- SEPN $27.00
- AVG Volume (30 Days)
- TTI 1.2M
- SEPN 2.6M
- Earning Date
- TTI 04-29-2025
- SEPN 05-15-2025
- Dividend Yield
- TTI N/A
- SEPN N/A
- EPS Growth
- TTI 426.72
- SEPN N/A
- EPS
- TTI 0.84
- SEPN N/A
- Revenue
- TTI $605,279,000.00
- SEPN $977,000.00
- Revenue This Year
- TTI $2.67
- SEPN N/A
- Revenue Next Year
- TTI $7.55
- SEPN N/A
- P/E Ratio
- TTI $3.05
- SEPN N/A
- Revenue Growth
- TTI N/A
- SEPN 108.76
- 52 Week Low
- TTI $2.03
- SEPN $4.17
- 52 Week High
- TTI $5.12
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- TTI 41.93
- SEPN N/A
- Support Level
- TTI $2.68
- SEPN N/A
- Resistance Level
- TTI $2.82
- SEPN N/A
- Average True Range (ATR)
- TTI 0.12
- SEPN 0.00
- MACD
- TTI -0.02
- SEPN 0.00
- Stochastic Oscillator
- TTI 6.72
- SEPN 0.00
About TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.